Literature DB >> 12637571

Regulation of vascular endothelial growth factor binding and activity by extracellular pH.

Adrienne L Goerges1, Matthew A Nugent.   

Abstract

Angiogenesis, the growth of new blood vessels, is regulated by a number of factors, including hypoxia and vascular endothelial growth factor (VEGF). Although the effects of hypoxia have been studied intensely, less attention has been given to other extracellular parameters such as pH. Thus, the present study investigates the consequences of acidic pH on VEGF binding and activity in endothelial cell cultures. We found that the binding of VEGF165 and VEGF121 to endothelial cells increased as the extracellular pH was decreased from 7.5 to 5.5. Binding of VEGF165 and VEGF121 to endothelial extracellular matrix was also increased at acidic pH. These effects were, in part, a reflection of increased heparin binding, because VEGF165 and VEGF121 showed increased retention on heparin-Sepharose at pH 5.5 compared with pH 7.5. Consistent with these findings, soluble heparin competed for VEGF binding to endothelial cells under acidic conditions. However, at neutral pH (7.5) low concentrations of heparin (0.1-1.0 microg/ml) potentiated VEGF binding. Extracellular pH also regulated VEGF activation of the extracellular signal-regulated kinases 1 and 2 (Erk1/2). VEGF165 and VEGF121 activation of Erk1/2 at pH 7.5 peaked after 5 min, whereas at pH 6.5 the peak was shifted to 10 min. At pH 5.5, neither VEGF isoform was able to activate Erk1/2, suggesting that the increased VEGF bound to the cells at low pH was sequestered in a stored state. Therefore, extracellular pH might play an important role in regulating VEGF interactions with cells and the extracellular matrix, which can modulate VEGF activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637571     DOI: 10.1074/jbc.M211208200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Effects of acid-base balance and high or low intensity exercise on VEGF and bFGF.

Authors:  Patrick Wahl; Christoph Zinner; Silvia Achtzehn; Michael Behringer; Wilhelm Bloch; Joachim Mester
Journal:  Eur J Appl Physiol       Date:  2010-12-15       Impact factor: 3.078

2.  Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability.

Authors:  Ding Xu; Mark M Fuster; Roger Lawrence; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

3.  Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.

Authors:  Madelane Teran; Matthew A Nugent
Journal:  J Biol Chem       Date:  2015-05-15       Impact factor: 5.157

Review 4.  Heparan sulfate-protein binding specificity.

Authors:  M A Nugent; J Zaia; J L Spencer
Journal:  Biochemistry (Mosc)       Date:  2013-07       Impact factor: 2.487

5.  Heparin potentiates Avastin-mediated inhibition of VEGF binding to fibronectin and rescues Avastin activity at acidic pH.

Authors:  Divyabharathy Tsiros; Casey E Sheehy; Surenna Pecchia; Matthew A Nugent
Journal:  J Biol Chem       Date:  2019-10-10       Impact factor: 5.157

6.  Tandem mass spectrometry of heparan sulfate negative ions: sulfate loss patterns and chemical modification methods for improvement of product ion profiles.

Authors:  Xiaofeng Shi; Yu Huang; Yang Mao; Hicham Naimy; Joseph Zaia
Journal:  J Am Soc Mass Spectrom       Date:  2012-07-24       Impact factor: 3.109

7.  PDGF-A interactions with fibronectin reveal a critical role for heparan sulfate in directed cell migration during Xenopus gastrulation.

Authors:  Erin M Smith; Maria Mitsi; Matthew A Nugent; Karen Symes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

8.  Association of Bordetella dermonecrotic toxin with the extracellular matrix.

Authors:  Aya Fukui-Miyazaki; Shigeki Kamitani; Masami Miyake; Yasuhiko Horiguchi
Journal:  BMC Microbiol       Date:  2010-09-25       Impact factor: 3.605

9.  Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.

Authors:  Arivalagan Muthusamy; Carlton R Cooper; Ronald R Gomes
Journal:  BMC Biochem       Date:  2010-11-03       Impact factor: 4.059

10.  Microenvironment changes (in pH) affect VEGF alternative splicing.

Authors:  Ana Paula Elias; Sergio Dias
Journal:  Cancer Microenviron       Date:  2008-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.